MedPath

Whole- Body Vibration Among Egyptian Elderly With Sarcopenia

Not Applicable
Active, not recruiting
Conditions
Sarcopenia
Interventions
Other: aerobic exercises
Device: Whole-body vibration
Other: resistance exercises
Registration Number
NCT06293573
Lead Sponsor
Cairo University
Brief Summary

To investigate and compare between the effectiveness of whole body vibration and aerobic training exercises in management of sarcopenia, muscle mass, physical performance and muscle strength in elderly.

Detailed Description

Participants will be assigned randomly into two groups of equal number (study group A and study group B ) the randomization will be performed by computerized randomization. Assessors will be blinded to the groups of the subjects.

c- Subject selection 84 patients with sarcopenia will participate in this study and will be divided randomly into three equal groups with 28 participants in each group.

d- Groups: Group A (Study group): Will receive whole body vibration exercises with conventional progressive resistance exercises and diet modification life style Group B (Study group): Will receive aerobic exercises training with conventional progressive resistance exercises and diet modification life style.

Group C (Control Group): will receive conventional progressive resistance exercises and diet modification life style.

During the study, the participants will receive study information form, instructions and signed the consent form.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
84
Inclusion Criteria
  1. patients age older than 60 years

  2. patients with Skeletal muscle index (SMI) below 8.87 kg/m2 and 6.42 kg/m2 in males and females, respectively.

  3. patients with hand grip strength below < 27 kg in men and < 16 kg in women.

  4. patients with no regular exercise habit for more than 3 months .

  5. patients with gait speed > 0.8 m/s.

  6. patients with proper conscious and cognition that will be detected by using Mini Mental State Examination(scores > 21).

Read More
Exclusion Criteria

acute injury. 2- severe heart diseases. 3- pacemaker. 4-history of orthopedic surgery of the lower limbs and/or fracture less than 1 year earlier.

.5 - inability to walk without assistance. 6-neurological diseases or acute conditions that would interfere with testing and training.

7-patients with improper conscious and cognition that will be detected by using Mini Mental State Examination(scores < 21).

8- patients who cannot exercise at all due to conditions like deep vein thrombosis or blood clotting issues.

9- patients with severe illnesses that influence assessments and interventions, such as those with disabilities or musculoskeletal conditions (such as fracture, dislocation, osteoporosis, and rheumatoid arthritis).

10- People with major spinal conditions or surgical histories, such as cauda equina syndrome, tumor, vertebral fracture, inflammatory joint disease, spondylolisthesis, and ankylosing spondylitis.

Every participant will get a primary checkup to get a full picture of their health, find out if there are any restrictions, and decide whether they can take part in the study.

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
aerobic exercise groupresistance exercisesGroup B (Study group): Will receive aerobic exercises training with conventional progressive resistance exercises and diet modification life style.
whole body vibration groupresistance exercisesGroup A (Study group): Will receive whole body vibration exercises with conventional progressive resistance exercises and diet modification life style
aerobic exercise groupaerobic exercisesGroup B (Study group): Will receive aerobic exercises training with conventional progressive resistance exercises and diet modification life style.
conventional resistance exercise groupresistance exercisesGroup C (Control Group): will receive conventional progressive resistance exercises and diet modification life style
whole body vibration groupWhole-body vibrationGroup A (Study group): Will receive whole body vibration exercises with conventional progressive resistance exercises and diet modification life style
Primary Outcome Measures
NameTimeMethod
Muscle MassMuscle mass will be investigated at baseline and after the treatment period of 12 weeks.

Outcome measures included:

• Skeletal muscle mass (SMM): will be measured by Bioimpedance analysis using body composition analyzer (InBody Dial H 20b).

muscle strengthMuscle strength will be investigated at baseline and after the treatment period of 12 weeks.

will be measured by using calibrated handheld dynamometer (CAMRY EH101).

400 m Walking Test400 m Walking Test will be investigated at baseline and after the treatment period of 12 weeks.

The 400-meters walk test evaluates a person's stamina and ability to walk. Participants in this test are required to run 20 laps of 20 meters, each lap as quickly as they can, and are permitted up to two rest breaks throughout the test.

Gait Speed testGait speed test will be investigated at baseline and after the treatment period of 12 weeks.

The 4-m usual walking speed test, which measures speed either manually ,with a stopwatch or instrumentally, with an electronic device, to measure gait timing.

timed Up and Go Test (TUG)Timed Up and Go Test will be investigated at baseline and after the treatment period of 12 weeks.

The TUG test evaluates physical function, individuals will be asked to rise from a standard chair, walk to a marker 3 m away from the chair, turn around, walk back, and sit down again.

Six minute walk test (6MWT)Six Minutes Walk Test will be investigated at baseline and after the treatment period of 12 weeks.

6MWT is used to measure a patient's exercise tolerance. Also it is used to assess aerobic capacity and endurance. Patient is asked to walk at his normal pace for six minutes.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Faculty of Physical Therapy

🇪🇬

Dokki, Giza, Egypt

© Copyright 2025. All Rights Reserved by MedPath